Trial of steroid withdrawal in renal transplant recipients with long-term--surviving allograft.
Mizuno
Y
Y
Second Department of Surgery, Tohoku University School of Medicine, Sendai, Japan.
Kikuchi
H
H
Fujimori
K
K
Doi
H
H
Orii
T
T
Ohkohchi
N
N
Satomi
S
S
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D007166:Immunosuppressive Agents; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D011239:Prednisolone; D003404:Creatinine; D001379:Azathioprine